These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3753158)
1. Toward a more reliable diagnosis of akathisia. Van Putten T; Marder SR Arch Gen Psychiatry; 1986 Oct; 43(10):1015-6. PubMed ID: 3753158 [No Abstract] [Full Text] [Related]
7. Management of akathisia in a severely retarded adolescent male with help of an anticholinergic drug assay. Harris JC; Tune LE; Allen M; Coyle JT Lancet; 1981 Aug; 2(8243):414. PubMed ID: 6115172 [No Abstract] [Full Text] [Related]
8. Akathisia: a distressing complication of neuroleptic treatment. Szabadi E Compr Ther; 1987 Sep; 13(9):3-6. PubMed ID: 2889560 [No Abstract] [Full Text] [Related]
9. [Managing agitation in acute psychotic episodes of schizophrenia]. Thomas P Encephale; 2006 Jan; 32 Pt 2():S12-3. PubMed ID: 16800080 [No Abstract] [Full Text] [Related]
10. The classification of akathisia. Sachdev P Mov Disord; 1995 Mar; 10(2):235-7. PubMed ID: 7753075 [No Abstract] [Full Text] [Related]
12. Low plasma iron status and akathisia. Barton A; Bowie J; Ebmeier K J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):671-4. PubMed ID: 1976763 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced movement disorders in institutionalised adults with mental retardation: clinical characteristics and risk factors. Sachdev P Aust N Z J Psychiatry; 1992 Jun; 26(2):242-8. PubMed ID: 1353672 [TBL] [Abstract][Full Text] [Related]
14. Serum iron and transferrin in acute neuroleptic induced akathisia. O'Loughlin V; Dickie AC; Ebmeier KP J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):363-4. PubMed ID: 1676049 [TBL] [Abstract][Full Text] [Related]
15. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321 [TBL] [Abstract][Full Text] [Related]
16. [Akathisia, a literature review]. van der Kruijk RA; Dominicus W Ned Tijdschr Geneeskd; 1988 Sep; 132(37):1684-6. PubMed ID: 2902521 [No Abstract] [Full Text] [Related]
17. Safety of long-term neuroleptanxiolysis with fluspirilene 1.5 mg per week. Tegeler J; Lehmann E; Weiher A; Heinrich K Pharmacopsychiatry; 1990 Nov; 23(6):259-64. PubMed ID: 2284327 [TBL] [Abstract][Full Text] [Related]
19. The syndrome of motor restlessness--a treatable but under-recognised disorder. Bakheit A Postgrad Med J; 1997 Sep; 73(863):529-30. PubMed ID: 9373589 [No Abstract] [Full Text] [Related]
20. Diabetes, tardive dyskinesia, parkinsonism, and akathisia in schizophrenia: a retrospective study applying 1998 diabetes health care guidelines to antipsychotic use. Lévy E; Margolese HC; Annable L; Chouinard G Can J Psychiatry; 2004 Jun; 49(6):398-402. PubMed ID: 15283536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]